Paragraph IV Disputes
April 29-30, 2019 | The Conrad – New York, NY
TO REGISTER, CLICK HERE »
You can save an extra 10% off the current rate by using code D10-999-JDS19.
ACI’s Paragraph IV Disputes provides Hatch-Waxman stakeholders with practical information on cutting edge developments that affect both substantive and procedural matters of import for both the brand name and generic sides of the industry.
With hundreds of attendees expected from the United States — and across the world, we hope that you will join us this April to meet and reconnect with peers, acquire firsthand insights from industry luminaries, and acquire invaluable “take aways” for legal strategies and cost-analysis for every facet of this complex litigation, from pre-suit considerations to case filings through final adjudication.
Click here to learn more about this conference »
NEW for 2019!
THE FEDERAL CIRCUIT:
Fireside chat with the Hon. Kathleen M. O’Malley, United States Circuit Judge
FTC KEYNOTE:
Hear directly from Markus Meier, Assistant Director of the Bureau of Competition’s Health Care Division
MAGISTRATE JUDGES TOWN HALL:
Perspectives from the Districts of NJ, Del, E.D Tex.
FDA INSIGHTS:
Learn from members of the FDA’s new Hatch-Waxman Working Group
TWO JUDICIAL ROUNDTABLES:
Insights from the District Court and PTAB
SIX BREAKOUT TRACKS:
Covering budgeting, trial preparation, and international concerns
Download the conference agenda brochure here »
Meet our Co-Chairs
“This is the best high-level conference on Paragraph IV disputes...”
Guy Donatiello
Senior Vice President, Intellectual Property at Endo Pharmaceuticals
“…the smaller breakout sessions allow participants to tailor their conference experience to meet their specific needs, and exchange ideas in an intimate and dynamic environment.”
Pearl T.L. Siew
Senior Vice President and Head, Intellectual Property at Eagle Pharmaceuticals
Confirmed speakers include:
Get judicial insights on the complex challenges facing both brand name and generic drug manufacturers:
United States Court of Appeals for the Federal Circuit
Honorable Kathleen M. O’Malley
United States Circuit Judge, United States Court of Appeals for the Federal Circuit
United States District Court
Honorable Stanley R. Chesler
United States District Judge, District of New Jersey
Honorable Renee M. Bumb
United States District Judge, District of New Jersey
Honorable Tonianne J. Bongiovanni
Magistrate Judge, District of New Jersey
Honorable Mary Pat Thynge
Chief Magistrate Judge, District of Delaware
Honorable Christopher J. Burke
Magistrate Judge, District of Delaware
Honorable Ruben Castillo
Chief Judge, Northern District of Illinois
Honorable Roy Payne
Magistrate Judge, Eastern District of Texas
United States Patent and Trademark Office, Patent Trial and Appeal Board
Honorable Jacqueline Wright Bonilla
Vice Chief, Administrative Patent Judge
Honorable Michelle N. Ankenbrand
Lead Administrative Patent Judge
Honorable Rama G. Elluru
Administrative Patent Judge
Hear from the FTC and the FDA on the latest antitrust and regulatory developments impacting Paragraph IV litigation
Markus H. Meier
Assistant Director, Health Care Division, Bureau of Competition
Grail Sipes
Deputy Center Director for Regulatory, Policy, CDER
Maryll Toufanian
Director, FDA Office of Generic Drug, Policy, CDER
Click here to see the confirmed list of speakers »
Who you will meet
Patent attorneys and litigators (in-house & law firms) who represent:
-
Brand name pharmaceutical companies
-
Generic pharmaceutical companies
-
Biopharmaceutical companies
REGISTER NOW and save an extra 10% off the conference by using code D10-999-JDS19.
AmericanConference.com/PIVDisputes | 888 224 2480
*Discount is valid for new registration only and it’s not applicable for workshops.
